NEW ROCHELLE, NY — April 26, 2004
According to a recent study published in the New England Journal of Medicine, only about half of patients receive standard of care treatment. To provide health care professionals with up-to-date standard of care treatment information, The Medical Letter today released the PDA version of Treatment Guidelines from The Medical Letter, a publication that provides authoritative drug prescribing recommendations. Treatment Guidelines, also available in print and online, provides physicians and other healthcare professionals with unbiased drug treatment recommendations for common diseases.
"The unique editorial process used to produce Treatment Guidelines results in prescribing recommendations that are free of pharmaceutical influence," said deputy editor Gianna Zuccotti, M.D., M.P.H. "Now these trusted recommendations can be easily accessed by physicians through their PDA."
Each month, Treatment Guidelines from The Medical Letter provides prescribing and formulary recommendations for diseases such as diabetes, asthma, osteoporosis, hypertension, rheumatoid arthritis, heart failure, cancer, high cholesterol levels, epilepsy, pain, depression, as well as treatment of bacterial, fungal and viral infections. The print, online and PDA versions (Palm OS only) also contain invaluable retail price comparison and dosage charts.
About The Medical Letter
The Medical Letter Inc., a nonprofit organization founded in 1958, offers health care professionals objective, independent analyses of both prescription and over-the-counter drugs. In addition to its newsletters, The Medical Letter on Drugs and Therapeutics and Treatment Guidelines from The Medical Letter, it also publishes handbooks and software on topics such as adverse drug interactions and antimicrobial therapy. The Medical Letter, Inc., is supported entirely by subscriber fees and is based in New Rochelle, NY. For more information about The Medical Letter call (800) 211-2769 or visit their Web site at www.medicalletter.org.
The Medical Letter
914.235.0500 ext. 345